The ICNMD 2016 Scientific Committee would like to thank everyone for submitting their abstracts. We look forward to seeing your Poster Presentations at the Congress.
The congress abstracts have been published through the Journal of Neuromuscular Disease and are now available online here.
Group 1 – Muscle Diseases of Genetic Origin: Clinical Features, Pathophysiology, Therapy
1.2 Muscle Dystrophies (Non-Dystrophinopathy)
1.3 Congenital Muscular Dystrophy
1.4 Congenital Myopathies / Myopathies with Prominent Muscle Contractures
1.5 Distal Myopathy / Myofibrillar Myopathies
1.6 Myotonic Myopathies
1.7 Facioscapulohumeral Muscular Dystrophies / Oculopharyngeal Muscular Dystrophy
1.8 Metabolic Myopathies / Mitochondrial Myopathies
1.9 Muscle Channelopathies and Related Disorders
1.10 Other Myopathies Including GNE – Hereditary Inclusion Body Myopathy
Group 2 – Acquired Myopathies: Clinical Features, Pathophysiology, Therapy
2.1 Inflammatory / Dysimmune Myopathies
2.2 Inclusion Body Myositis
2.3 Toxic / Endocrine / Other Acquired Myopathies
Group 3 – Diseases of Neuromuscular Junction: Clinical Features, Pathophysiology, Therapy
3.1 Myasthenia Gravis
3.2 Myasthenic Syndromes
3.3 Congenital Myasthenia
Group 4 – Peripheral Neuropathy: Clinical Features, Pathophysiology, Therapy
4.1 Inflammatory / Dysimmune / Associated with Monoclonal Gammopathy/Paraneoplastic
4.2 Hereditary Peripheral Neuropathy
4.3 Metabolic / Toxic
4.4 Infectious Peripheral Neuropathy (including Leprosy, HIV)
Group 5 – Motor Neuron Diseases: Clinical Features, Pathophysiology, Therapy
5.1 Biology, Genetics
5.2 Biomarkers in MND
5.3 Epidemiology, Clinic, Treatment
5.4 Spinal Muscular Atrophy / Neuronopathies
Group 6 – Novel Diagnostic Methods in Neuromuscular Diseases
6.3 Other Biomarkers
6.5 Small Nerve Fibre Evaluation
6.6 Biochemical and Molecular Techniques
Group 7 – Basic Sciences in Neuromuscular Diseases
7.1 Muscle Homeostasis / Muscle Regeneration
7.2 Muscle Structure / Muscle Development / Muscle Growth
7.3 Muscle Atrophy / Degeneration
7.4 Nuclear Envelope / Nuclear Matrix of Muscle Cell
7.5 Ion Channel Function in Neuron and Muscle
7.6 Immune Mechanisms in Neuromuscular Diseases
7.7 Fundamental Approaches to Motor Neuron, Axon and Related Structures
7.8 Neuromuscular Junction: Basic Aspects
Group 8 – Miscellaneous
8.1 Outcome Measures in Clinical Trials
8.2 Biomarkers in Neuromuscular Disorders
8.3 Home Care / Social Programs in Neuromuscular Diseases
8.4 Psychological and Neuropsychological Approaches in Neuromuscular Diseases
8.5 Ethics in Neuromuscular Disorders
8.6 Rehabilitation in Neuromuscular Diseases
The regular deadline for submitting abstracts is March 18, 2016, 23:59 (PST) .
Late breaking abstracts deadline is April 30, 2016
Submitting an abstract does not register you for ICNMD 2016; you must register for the Congress. Please click here to register.
Previously published or presented abstracts (Encore Abstracts) will be accepted.
Click here to submit a Poster Abstract. Paper and disk submissions will NOT be accepted. Abstracts can only be submitted online. ICNMD 2016 organizers expect that all abstracts selected for presentation will be presented by the authors and that submitted abstracts will not be withdrawn. Please do not submit an abstract if you are not able to travel to the Congress and present it in the form selected.
If you have any question regarding the abstract submission process, please send us an email
How to create my account?
If you have not yet registered or submitted an abstract with ICNMD 2016, click “Create an Account”. After being redirected to the account registration page you may fill in all personal and professional information as requested. You will then be asked to choose a password. A message giving your personal code and summarizing the data entered will then be sent to you by email and will give you the instructions to follow to finalise your submission / registration. Then you are now ready to return to the abstract submission page.
Step 1: How to submit my abstract?
Your abstract must contain:
Step 2: Select the Type,”Open Submission”, and a topic
Please select the Type, “Open Submission” and a topic of your abstract in the proposed list. It will be used to allow to dispatch your abstract for review to members of the Abstract Review Committee and to schedule the session for the presentation of your abstract.
Step 3: Title
Step 4: Authors
You should first create the list of authors and coauthors before considering submitting your abstracts. Authors will appear in alphabetical order. You can then change the order according to your choice and select the first author and the presenting author..
Step 5: Text
Step 6: Attachment
To complete your abstract, you are allowed to add one table as an attachment. It could be a document saved under the compatible following formats only: .jpeg, .jpg, .gif, .bmp, .png
Step 7: Disclosure
If relevant, don’t forget to indicate disclosure in the designed field.
Step 8: Validation and submission
The abstract is automatically registered under a “Draft” status. As long as this status is ongoing you can change your abstract until deadline by coming back to the submit page using your code…
IMPORTANT: Abstracts with a “Submitted” status only will be forwarded to the Scientific Committee. So it’s under your responsibility to make sure you get a submitted status by clicking on the “submit” arrow before deadline (1 March, 2016, midnight PST).
After clicking the “Submit” link, you will receive an email confirmation of your submission.
Step 9: Evaluation
After the submission deadline has been reached, abstracts will be dispatched to the members of the Review Abstract Committee, according to the mentioned topics. Based upon the ratings, the Review Abstract Committee will select the abstracts accepted for a poster presentation.
All submitters will then receive the final status (accepted or rejected) by email. The result will also be available online.
Organization of Poster Flash sessions and Poster Highlight sessions will take more time and presenting authors of the abstracts selected for presentation in these specific sessions will be directly contacted by email, at least 2 weeks before the meeting.